Novo Nordisk's recent decline suggests it may be a Buy again, with strong growth prospects in diabetes and obesity treatments ...

In trading on Tuesday, shares of Novo-Nordisk AS (Symbol ... and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of NVO shares: Looking ...